{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:28:31Z","timestamp":1792290511088,"version":"4.4.0"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":572,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Apheresis"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> The BioLogic\u2010DTPF System combines hemodiabsorption (the BioLogic\u2010DT System with dialysis against powdered sorbent) with push\u2010pull sorbent\u2010based pheresis (the BioLogic\u2010PF System with powdered sorbent surrounding plasma filters). At blood flow rates of 200 ml\/min, the system clears creatinine and aromatic amino acids at 120\u2013160 ml\/min, unconjugated bilirubin at 20\u201340 ml\/min, and cytokines at 15\u201325 ml\/min. This article outlines a study of the DTPF System in treatment of patients with hepatic failure with Grade 3 or 4 encephalopathy and respiratory and kidney insufficiency. Treatment appeared to be safe, and there are no significant hematologic changes. Physiologic changes include improved blood pressure and encephalopathy and stable urine output. Chemical changes include decrease in plasma levels of bilirubin, aromatic amino acids, ammonium, creatinine, and interleukin\u2010\u03b2 (IL\u20101\u03b2). The BioLogic\u2010DT System is now marketed for treatment of acute hepatic failure with encephalopathy. The BioLogic\u2010DTPF System adds the capability of removing bilirubin and other strongly protein\u2010bound toxins from treated patients and may be of clinical benefit in management of patients with the most severe hepatic failure and encephalopathy.<\/jats:p>","DOI":"10.1046\/j.1526-0968.2000.00192.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T20:59:58Z","timestamp":1047502798000},"page":"218-228","source":"Crossref","is-referenced-by-count":36,"title":["Push\u2010Pull Sorbent\u2010Based Pheresis and Hemodiabsorption in the Treatment of Hepatic Failure: Preliminary Results of a Clinical Trial with the BioLogic\u2010DTPF\u2003System"],"prefix":"10.1111","volume":"4","author":[{"given":"S.R.","family":"Ash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.R.","family":"Knab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Harker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889101400401"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1994.tb02216.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889401701207"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.7182\/prtr.1.8.1.625l0438071k6182"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199339030-00100"},{"key":"e_1_2_6_7_2","first-page":"101","article-title":"BioLogic\u2010DT System in treatment of acute hepatic coma; results of randomized, prospectively controlled trials.","volume":"25","author":"Ash S","year":"1996","journal-title":"J Hepatology"},{"key":"e_1_2_6_8_2","first-page":"497A","article-title":"Hemodiabsorption (the Biologic\u2010DT System) in treatment of hepatic failure with encephalopathy: Summary of randomized prospective controlled clinical trials.","volume":"28","author":"Ash S","year":"1998","journal-title":"Hepatology"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889902200107"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1992.tb00288.x"},{"key":"e_1_2_6_11_2","first-page":"576","article-title":"Extracorporeal blood purification in the management of patients with hepatic failure.","volume":"17","author":"Kaplan AA","year":"1997","journal-title":"Semin Nephrol"},{"key":"e_1_2_6_12_2","first-page":"215","volume-title":"Multiple Systems Organ Failure.","author":"Gokal AKJ","year":"1993"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199705000-00005"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199703000-00305"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199805000-00004"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.1999.06232.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199809000-00072"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1994.tb02214.x"},{"key":"e_1_2_6_19_2","first-page":"517","volume-title":"The Kidney in Liver Disease.","author":"Perez GO","year":"1996"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1994.tb02217.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199642030-00022"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30647-2"},{"key":"e_1_2_6_23_2","first-page":"148","volume-title":"Clinical Management of Poisoning and Drug Overdose.","author":"Winchester JF","year":"1990"},{"key":"e_1_2_6_24_2","first-page":"115","article-title":"Clinical experience with the use of charcoal haemoperfusion: Is prostacyclin required?","volume":"3","author":"Kennedy HJ","year":"1985","journal-title":"Life Support Syst"},{"key":"e_1_2_6_25_2","first-page":"239","article-title":"Biochemical correlations of reversal of hepatic coma treated with charcoal hemoperfusion.","volume":"24","author":"Gelfand MC","year":"1978","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0300-5089(21)00017-1","article-title":"Fulminant hepatic failure.","volume":"10","author":"Tygstrup N","year":"1981","journal-title":"Clin Gastroenterol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.22.140"},{"key":"e_1_2_6_28_2","first-page":"140","volume-title":"Past Present and Future of Artificial Organs.","author":"Niu Z","year":"1983"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90661-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90711-5"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90011-X"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889101400401"},{"key":"e_1_2_6_33_2","first-page":"331","volume-title":"Progress in Liver Diseases.","author":"Demetriou AA","year":"1995"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316501"},{"key":"e_1_2_6_35_2","first-page":"1446","article-title":"Pilot controlled trial of the extracorporeal liver assist device in acute liver failure.","volume":"26","author":"Ellis AJ","year":"1994","journal-title":"Hepatology"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90678-3"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.1996.tb00646.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90183-X"},{"key":"e_1_2_6_39_2","first-page":"141A","article-title":"Contribution of leukocytes to hepatic graft injury following cold preservation and transplantation.","volume":"20","author":"Kawano K","year":"1994","journal-title":"Hepatology"},{"key":"e_1_2_6_40_2","first-page":"77","article-title":"The effect of normalization of plasma amino acids on hepatic encephalopathy in man.","volume":"80","author":"Fisher JE","year":"1976","journal-title":"Surgery"}],"container-title":["Therapeutic Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-0968.2000.00192.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-0968.2000.00192.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:35:10Z","timestamp":1698604510000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-0968.2000.00192.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1526-0968.2000.00192.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-0968.2000.00192.x","archive":["Portico"],"relation":{},"ISSN":["1091-6660","1526-0968"],"issn-type":[{"value":"1091-6660","type":"print"},{"value":"1526-0968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}